Holders

ZENAS BIOPHARMA INC

Q1 2026 13F holders

CUSIP
98937LAA3
Type
Debt
Class
NOTE 2.500% 4/0
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type